Syndel and Alpharma, the best vaccines are back!

December 14^th, 2001

Syndel International is pleased to announce the approval in Canada of Alpharma’s ALPHAJECT 4000 vaccine for use in salmonids. Dr. Jim Brackett (General Manager, Syndel International) says:  “We are extremely pleased to offer Alpharma’s new vaccine to the Canadian Aquaculture industry.  This important new vaccine complements our other approved products for our customers and helps us to support our customers’ profitability.”

ALPHAJECT 4000 represents the “next generation” of oil-based vaccines and is the culmination of years of research.  The new vaccine provides unsurpassed protection against furunculosis (Aeromonas salmonicida), Vibriosis (Vibrio anguillarum serotype I and II) and cold water Vibriosis (Hitra, Vibrio salmonicida). The new adjuvant system also helps to reduce side effects such as adhesions and melanisations.

Alpharma employs its vast experience in manufacturing and distribution to provide vaccines around the world “The Canadian approval is important, and Alpharma can now offer fish vaccines in all the important salmon and trout markets and is better equipped to service global aquaculture players' needs," said Alpharma Marketing Director Jan Oppen Berntsen.  More fish have been vaccinated with Alpharma vaccines than all other fish vaccines combined.

. 

 Get the best protection possible for your investment with the fewest possible side effects. Call Syndel today for a very competitive quote (1-800-663-2282).